Skip to main content
SpringerLink
Log in

Plasminogen activation in epiretinal membranes

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

• Background: Formation of epiretinal membranes occurs in proliferative vitreoretinopathy, macular pucker and after penetrating trauma. Epiretinal membrane formation includes cell migration and proliferation, extracellular matrix formation and tissue contraction. Generally in scar tissue formation, the production of new extracellular matrix occurs concomitantly with its proteolytic degradation, resulting in continuous tissue remodelling. The plasminogen activator-mediated proteolytic cascade is an important mechanism for pericellular degradation of the extracellular matrix. Therefore we wanted to study the presence of the plasminogen activator-mediated proteolytic cascade in epiretinal membranes. • Methods: Specimens of 18 epiretinal and 3 subretinal membranes were obtained during vitreous surgery for retinal detachment with proliferative vitreoretinopathy or macular pucker. Plasminogen activators and plasmin were characterized in frozen sections of epiretinal membranes by in situ zymography and in membrane lysates by zymography. Indirect immunofluorescence staining was performed to localize urokinase in epiretinal membranes. • Results: Urokinase was present in 17/21 and tissue-type plasminogen activator in 12/21 of the membranes studied. Active plasmin was not detected in the frozen sections of epiretinal membranes. Immunofluorescence staining localized urokinase predominantly in the areas invaded by macrophages and cells of retinal pigment epithelial origin. • Conclusion: Our results demonstrate the presence of proteolytic activity in periretinal scar tissue. Urokinase was more consistently present, but smaller amounts of tissue-type plasminogen activator were also found in the specimens. These results indicate that continuous tissue remodelling with simultaneous extracellular matrix production and breakdown regulates the growth of epiretinal membranes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brinkedal-Hansen H (1993) Matrix metalloproteinases. J Periodontol 64:477–484

    Google Scholar 

  2. Clarkson JG, Green WR, Massof D (1977) A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol 84:1–17

    Google Scholar 

  3. Gailit J, Clark RAF (1994) Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 6:717–725

    Google Scholar 

  4. Granelli-Piperno A, Reich E (1978) A study of protease and protease-inhibitor complexes in biological fluids. J Exp Med 146:223–234

    Google Scholar 

  5. Greven CM, Slusher MM, Weaver RG (1988) Epiretinal membrane release and posterior vitreous detachment. Ophthalmology 95:902–905

    Google Scholar 

  6. Immonen I, Stephens RW, Salonen EM, Laatikainen L, Sim P-S, Vaheri A (1989) Tissue-type plasminogen activator in subretinal fluid. Curr Eye Res 8:249–252

    Google Scholar 

  7. Immonen I, Konttinen YT, Sorsa T, Tommila P, Siren V (1996) Proteinases in subretinal fluid. Graefe's Arch Clin Exp Ophthalmol 234:105–109

    Google Scholar 

  8. Kristensen P, Larsson LI, Nielsen LS, Grøndahl-Hansen J, Andreasen PA, Danø K (1984) Human endothelial cells contain one type of plasminogen activator. FEBS Lett 168:33–37

    Google Scholar 

  9. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685

    Google Scholar 

  10. Liotta LA, Goldfarb RH, Brundale R, Siegal GP, Terranova V, Garbiza S (1981) Effect of plasminogen activator (urokinase), plasmin and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41:4629–4636

    Google Scholar 

  11. Mietz H, Walshe R, Wiedemann P, Heimann K, Green WR (1994) Histopathologic study of epiretinal proliferations after vitrectomy with daunomycin and silicone oil. Retina 5:425–429

    Google Scholar 

  12. Morino I, Hiscott P, McKehnie N, Grierson I (1990) Variation in epiretinal membrane components with clinic duration of the proliferative tissue. Br J Ophthalmol 74:393–399

    Google Scholar 

  13. Niedbala MJ, Picarella MS (1992) Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by γ-interferon. Blood 79:678–687

    Google Scholar 

  14. Pöllänen J, Saksela O, Salonen E-M, Andreasen P, Nielsen L, Danø K, Vaheri A (1987) Distinct localization of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol 104:1085–1096

    Google Scholar 

  15. Pöllänen J, Stephens RW, Vaheri A (1991) Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 57:273–328

    Google Scholar 

  16. Ronne E, Behrendt N, Ellis V, Ploug M, Danø K, Høyer-Hansen G (1991) Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2 terminal domain of the urokinase receptor. FEBS Lett 288:233–236

    Google Scholar 

  17. Sirén V, Stephens RW, Salonen E-M, Vaheri A, Summanen P, Immonen I (1992) Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1. Ophthalmic Res 24:203–212

    Google Scholar 

  18. Sirén V, Vaheri A, Immonen I (1994) Secretion of plasminogen activators by cells cultured from subretinal fluid. Acta Ophthalmol 72:218–222

    Google Scholar 

  19. Stephens RW, Pöllänen J, Tapiovaara H, Leung KC, Sim PS, Salonen E-M, Rønne G, Behrendt N, Danø K, Vaheri A (1989) Activation of pro-urokinase and plasminogen on human sarcoma cells. A proteolysic system with surface-bound reactants. J Cell Biol 108:1987–1995

    Google Scholar 

  20. Tervo K, Latvala T, Suomalainen V-P, Tervo T, Immonen I (1995) Cellular fibronectin and tenascin in experimental perforating scleral wounds with incarceration of the vitreous. Graefe's Arch Clin Exp Ophthalmol 233:168–172

    Google Scholar 

  21. Tripathi BJ, Geanon JD, Tripathi RC (1987) Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study. Ophthalmology 94:1434–1438

    Google Scholar 

  22. Unkeless JC, Gordon S, Reich E (1974) Secretion of plasminogen activator by stimulated macrophages. J Exp Med 139:834–850

    Google Scholar 

  23. Vaheri A, Bizik J, Salonen E-M, Tapiovaara H, Sirén V, Myöhänen H, Stephens RW (1989) Regulation of the pericellular activation of plasminogen and its role in tissue-destructive processes. Acta Ophthalmol (Copenh) [Suppl 202] 70:34–41

    Google Scholar 

  24. Wiedemann P, Heimann K (1992) Proliferative vitreoretinopathy. Curr Opin Ophthalmol 3:357–365

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Helsinki University Hospital, Haartmaninkatu 4C, FIN-00290, Helsinki, Finland

    Ilkka Immonen & Petri Tommila

  2. Department of Virology, Haartman Institute, University of Helsinki, Helsinki, Finland

    Antti Vaheri & Vappu Sirén

Authors
  1. Ilkka Immonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antti Vaheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Petri Tommila
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vappu Sirén
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Immonen, I., Vaheri, A., Tommila, P. et al. Plasminogen activation in epiretinal membranes. Graefe's Arch Clin Exp Ophthalmol 234, 664–669 (1996). https://doi.org/10.1007/BF00292351

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00292351

Keywords

Search

Navigation